Accessibility Menu
 
Royalty Pharma Plc logo

Royalty Pharma Plc

(NASDAQ) RPRX

Current Price$49.45
Market Cap$21.98B
Since IPO (2020)+26%
5 Year+26%
1 Year+56%
1 Month+2%

Royalty Pharma Plc Financials at a Glance

Market Cap

$21.98B

Revenue (TTM)

$2.38B

Net Income (TTM)

$770.95M

EPS (TTM)

$1.78

P/E Ratio

27.78

Dividend

$0.90

Beta (Volatility)

0.48 (Low)

Price

$49.45

Volume

57,385

Open

$50.13

Previous Close

$49.45

Daily Range

$49.24 - $50.13

52-Week Range

$31.97 - $50.47

RPRX: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Royalty Pharma Plc

Industry

Pharmaceuticals

Employees

100

CEO

Pablo Gerardo Legorreta

Headquarters

New York City, NY 10022, US

RPRX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

66%

Net Income Margin

32%

Return on Equity

11%

Return on Capital

8%

Return on Assets

4%

Earnings Yield

3.60%

Dividend Yield

1.81%

Payout Ratio

49.06%

Stock Overview

Market Cap

$21.98B

Shares Outstanding

444.38M

Volume

57.38K

Avg. Volume

3.40M

Financials (TTM)

Gross Profit

$2.38B

Operating Income

$1.56B

EBITDA

$1.64B

Operating Cash Flow

$2.49B

Capital Expenditure

$0.00

Free Cash Flow

$2.49B

Cash & ST Invst.

$637.50M

Total Debt

$8.95B

Royalty Pharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$621.99M

+4.8%

Gross Profit

$621.99M

+4.8%

Gross Margin

100.00%

N/A

Market Cap

$21.98B

N/A

Market Cap/Employee

$293.11M

N/A

Employees

75

N/A

Net Income

$214.21M

+2.9%

EBITDA

$451.28M

+12.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$8.31B

-42.3%

Accounts Receivable

$883.70M

+3178.3%

Inventory

$0.00

N/A

Long Term Debt

$8.59B

+29.8%

Short Term Debt

$380.00M

-61.9%

Return on Assets

3.93%

N/A

Return on Invested Capital

8.21%

N/A

Free Cash Flow

$827.15M

+11.4%

Operating Cash Flow

$827.15M

+11.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ROIVRoivant Sciences Ltd.
$27.83-2.45%
INCYIncyte Corporation
$96.91+1.72%
UTHRUnited Therapeutics Corporation
$570.40-0.17%
HOLXHologic, Inc.
$76.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About RPRX

What is the current price of Royalty Pharma Plc?

Royalty Pharma Plc is trading at $49.45 per share.

What is the 52-week range for Royalty Pharma Plc?

Over the past 52 weeks, Royalty Pharma Plc has traded between $31.97 and $50.47.

How much debt does Royalty Pharma Plc have?

As of the most recent reporting period, Royalty Pharma Plc reported total debt of $8.97B.

How much cash does Royalty Pharma Plc have on hand?

Royalty Pharma Plc reported $618.70M in cash and cash equivalents in its most recent financial results.

What is Royalty Pharma Plc’s dividend yield?

Royalty Pharma Plc currently has a dividend yield of 1.81%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.